
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Technology Inc. is expected to benefit from a bolstered sales force and guided revenue growth for FY 2025, increasing by $6.5 million to a range of $317-$321 million, driven by a strong performance in the AffloVest business and lymphedema sector. The company is projected to maintain gross margins around 75%, while operational expenses are anticipated to rise by approximately 11% year-over-year, reflecting strategic investments to enhance productivity. Additionally, favorable market dynamics, including streamlined patient access and improved sales force efficiency, position Tactile Systems for continued growth and a strengthened market leadership in the medical device sector.
Bears say
Tactile Systems Technology Inc. has revised its lymphedema sales growth expectations downward, which negatively impacts their projected revenue for 4Q25, despite positive trends in the airway clearance segment. The company faces significant risks, including a slower-than-expected uptake in commercial channels, operational inefficiencies within the sales force, and heightened competition, all of which may constrain future growth. Concerns regarding the visibility of ongoing trends, particularly as they represent approximately 85% of revenues alongside two consecutive guidance downgrades, further contribute to a negative outlook on the company's financial health.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares